SHSE:600211 (China)
Â
Class A
Â¥
32.83
(+2.21%)
Jul 5
Business Description
Tibet Rhodiola Pharmaceutical Holding Co
NAICS : 325412
SIC : 2834
ISIN : CNE000000ZW7
Share Class Description:
SHSE:600211: Class ACompare
Compare
Traded in other countries / regions
600211.China IPO Date
1999-07-21Description
Tibet Rhodiola Pharmaceutical Holding Co is a Chinese company producing biological products and traditional Tibetan medicines.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.03 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.21 | |||||
Debt-to-EBITDA | 0.83 | |||||
Interest Coverage | 114.63 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 6.76 | |||||
Beneish M-Score | -2.96 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 31.6 | |||||
3-Year EBITDA Growth Rate | 21.1 | |||||
3-Year EPS without NRI Growth Rate | 29.1 | |||||
3-Year FCF Growth Rate | 71.3 | |||||
3-Year Book Growth Rate | 9.1 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.65 | |||||
9-Day RSI | 38.54 | |||||
14-Day RSI | 37.52 | |||||
6-1 Month Momentum % | 2.83 | |||||
12-1 Month Momentum % | -22.82 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.87 | |||||
Quick Ratio | 2.79 | |||||
Cash Ratio | 2.25 | |||||
Days Inventory | 256.61 | |||||
Days Sales Outstanding | 63.88 | |||||
Days Payable | 103.65 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 5.17 | |||||
Dividend Payout Ratio | 0.41 | |||||
3-Year Dividend Growth Rate | 37 | |||||
Forward Dividend Yield % | 5.17 | |||||
5-Year Yield-on-Cost % | 21.92 | |||||
Shareholder Yield % | 4.16 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 94.84 | |||||
Operating Margin % | 42.08 | |||||
Net Margin % | 27.65 | |||||
FCF Margin % | 37.46 | |||||
ROE % | 23.52 | |||||
ROA % | 16.96 | |||||
ROIC % | 57.35 | |||||
ROC (Joel Greenblatt) % | 139.18 | |||||
ROCE % | 26.19 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 13.05 | |||||
PE Ratio without NRI | 8.88 | |||||
Shiller PE Ratio | 30.06 | |||||
Price-to-Owner-Earnings | 15.88 | |||||
PEG Ratio | 0.59 | |||||
PS Ratio | 3.61 | |||||
PB Ratio | 2.89 | |||||
Price-to-Tangible-Book | 3.06 | |||||
Price-to-Free-Cash-Flow | 9.64 | |||||
Price-to-Operating-Cash-Flow | 9.48 | |||||
EV-to-EBIT | 8.75 | |||||
EV-to-EBITDA | 8.75 | |||||
EV-to-Revenue | 2.74 | |||||
EV-to-FCF | 7.32 | |||||
Price-to-Projected-FCF | 1.03 | |||||
Price-to-Median-PS-Value | 0.71 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.54 | |||||
Price-to-Graham-Number | 1.1 | |||||
Price-to-Net-Current-Asset-Value | 4.25 | |||||
Price-to-Net-Cash | 6.42 | |||||
Earnings Yield (Greenblatt) % | 11.43 | |||||
FCF Yield % | 10.61 | |||||
Forward Rate of Return (Yacktman) % | 21.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tibet Rhodiola Pharmaceutical Holding Co Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 2,931.612 | ||
EPS (TTM) (Â¥) | 2.516 | ||
Beta | 1.37 | ||
Volatility % | 32.54 | ||
14-Day RSI | 37.52 | ||
14-Day ATR (Â¥) | 0.929933 | ||
20-Day SMA (Â¥) | 34.321 | ||
12-1 Month Momentum % | -22.82 | ||
52-Week Range (Â¥) | 26.953846 - 46.884615 | ||
Shares Outstanding (Mil) | 322.32 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Tibet Rhodiola Pharmaceutical Holding Co Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Tibet Rhodiola Pharmaceutical Holding Co Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Tibet Rhodiola Pharmaceutical Holding Co Frequently Asked Questions
What is Tibet Rhodiola Pharmaceutical Holding Co(SHSE:600211)'s stock price today?
The current price of SHSE:600211 is ¥32.83. The 52 week high of SHSE:600211 is ¥46.88 and 52 week low is ¥26.95.
When is next earnings date of Tibet Rhodiola Pharmaceutical Holding Co(SHSE:600211)?
The next earnings date of Tibet Rhodiola Pharmaceutical Holding Co(SHSE:600211) is .
Does Tibet Rhodiola Pharmaceutical Holding Co(SHSE:600211) pay dividends? If so, how much?
The Dividend Yield %  of Tibet Rhodiola Pharmaceutical Holding Co(SHSE:600211) is 5.17% (As of Today), Highest Dividend Payout Ratio of Tibet Rhodiola Pharmaceutical Holding Co(SHSE:600211) was 1.89. The lowest was 0.11. And the median was 0.4. The  Forward Dividend Yield % of Tibet Rhodiola Pharmaceutical Holding Co(SHSE:600211) is 5.17%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |